Introduction
============

Acute obstructive suppurative pancreatic ductitis (AOSPD) is a rare disease defined as suppuration in the main pancreatic duct (MPD) without associated pseudocyst, abscess, or necrosis. It is a counterpart of acute obstructive suppurative cholangitis in the biliary tract. Weinman reported the first case in 1995 ([@B1]). A history of chronic pancreatitis (CP) or prior ampullary procedure \[*e.g.*, endoscopic sphincterectomy (EST) or endoscopic retrograde pancreatography (ERP)\], as well as pancreatic ductal obstruction, are considered necessary for the development of AOSPD ([@B1]-[@B11]). This case was considered unique because it was a rare case of spontaneous AOSPD associated with pancreatic ductal obstruction caused by pancreatic carcinoma in a patient without a history of CP or a previous ampullary procedure. To the best of our knowledge, there are no case reports of AOSPD with a similar pathogenesis.

Case Report
===========

A 68-year-old man with a history of type 2 diabetes mellitus (from 62 years of age) was referred to our hospital with complaints of subsequent epigastric and back pain, and a fever of 38.1°C. He had been smoking for 40 years but did not drink alcohol. Laboratory blood tests revealed a white blood cell count of 11,300/μL (reference range, 3,500-9,000 cells/mm^3^), a C-reactive protein concentration of 14.52 mg/dL (reference range, ＜0.30 mg/dL), and serum amylase concentration of 350 IU/L (reference range, 40-130 IU/L). With regard to diabetes mellitus, fasting blood sugar level was 134 mg/dL (reference range, 70-110 mg/dL), and his hemoglobin A1c concentration was 7.1% (reference range, 4.7-6.2%). His carcinoembryonic antigen 19-9 level was 85.4 IU/mL (reference range, ＜37 U/mL). Computed tomography (CT) showed a suspicious tumor in the body of the pancreas with a markedly dilated main pancreatic duct (MPD) ([Fig. 1A](#g001){ref-type="fig"}), and an edematous parenchyma with peripancreatic inflammatory changes limited to the tail of the pancreas ([Fig. 1B](#g001){ref-type="fig"}). CT and magnetic resonance cholangiopancreatography demonstrated slight dilation of the major ampulla-side MPD, 3 mm from the obstruction. However, there were no findings of CP (*e.g*., irregular MPD contour, dilated side branch, intraluminal protein plug). We did not detect abscess, pseudocyst, or calcification in the pancreas. The patient was admitted to our hospital with an initial diagnosis of acute obstructive pancreatitis caused by pancreatic carcinoma.

![Contrast CT. (A) MPD stricture in the body of the pancreas, along with a markedly dilated MPD in the pancreatic tail (arrow). (B) The edematous pancreatic tail with peripancreatic inflammatory changes (arrow).](1349-7235-57-1241-g001){#g001}

The patient was treated for acute pancreatitis (AP) with fluid resuscitation, antibiotics (meropenem hydrate 0.5 g, 3 times/day) and a protease inhibitor \[gabexate mesilate (300 mg, twice daily)\]. The patient\'s symptoms resolved on the eighth day after admission. Laboratory blood tests showed a reduced white blood cell count (7,900/μL) and serum amylase (102 IU/L); however, the patient\'s C-reactive protein level remained high (4.54 mg/dL).

On the ninth day after admission, we performed ERP to investigate the cause of the MPD obstruction. When a cannula tip was advanced beyond the stenosis deep into the distal MPD ([Fig. 2A](#g002){ref-type="fig"}), thick white pus was evacuated ([Fig. 2B](#g002){ref-type="fig"}). A bacteriological examination and aspirate culture revealed *Enterobacter cloacae.* A 5-Fr endoscopic nasopancreatic drainage (ENPD) tube was placed, and a cytological examination of the pancreatic juice revealed pancreatic adenocarcinoma.Two days after ENPD catheter placement, we confirmed that the pancreatic juice was clear. We therefore removed the ENPD catheter. Over a two-day period, the total volume of pancreatic juice output from the ENPD catheter was 335 mL. On the 23rd day after admission, he was discharged from hospital without an exacerbation of the symptoms.

![Endoscopic retrograde pancreatography. (A) A 10-mm-long stricture in the MPD, along with a markedly dilated MPD in the pancreatic tail. (B) Thick white pus was evacuated when a cannula tip was advanced deep into the distal pancreatic duct.](1349-7235-57-1241-g002){#g002}

Sixteen days after being discharged from our hospital, he was readmitted and pancreaticoduodenectomy was performed. As a result, an invasive ductal carcinoma of \~5 cm in size was identified in the body of the MPD ([Fig. 3A](#g003){ref-type="fig"}). A pathological examination revealed that most of the adenocarcinoma, including the MPD stricture, was *in situ*. Pancreatic parenchymal microinvasion was seen in places ([Fig. 3B](#g003){ref-type="fig"}), especially around the MPD stricture. There was a low level of pancreatic parenchymal fibrosis associated with the parenchymal invasion of the carcinoma. The obstruction of the MPD was caused by part of the carcinoma *in situ* with papillary growth. The papillae were short in height, unlike the long papillae (so-called finger-like papillae) found in intraductal papillary mucinous neoplasms; rich mucin production was not seen. Thus, the carcinoma was diagnosed as a papillary adenocarcinoma, but not intraductal papillary mucinous carcinoma. Neutrophilic infiltration was seen in the dilated MPD lumen of the pancreatic tail, and in the pancreatic stromal tissue around the dilated MPD of the pancreatic tail. Finally, we made a diagnosis of AOSPD caused by an MPD obstruction resulting from pancreatic carcinoma.

![The gross and histological findings. (A) The gross findings of the resected specimen. The stricture of the MPD was seen in the body of the pancreas (arrow). The carcinoma was unclear in the gross examination. (B) The histological examination. Adenocarcinoma was recognized. Most of the carcinoma, including the MPD stricture was *in situ*. Interstitial microinvasion was seen in places, with only a low level of fibrosis in the pancreatic parenchyma associated with intestinal invasion.](1349-7235-57-1241-g003){#g003}

Discussion
==========

Although no fatal cases of AOSPD have been reported, it frequently causes septic shock ([@B2], [@B5]-[@B7], [@B10], [@B11]). In the present case antibiotics resulted in an improvement of the patient\'s condition; however, several reports have described cases in which antibiotic treatment failed ([@B1]-[@B3], [@B6]-[@B8], [@B11]). For this reason, when AOSPD is suspected, the rapid drainage of the pancreatic duct with endoscopic intervention is desirable. However, most of the reported cases of AOSPD were initially misdiagnosed and treated as mild AP ([@B2], [@B4]) or acute-on-CP ([@B1], [@B3], [@B6]-[@B8]). It is difficult to differentiate AOSPD from AP and acute-on-CP, because there are no significant differences in their clinical features, imaging findings, or laboratory findings. Thus far, 29 cases of AOSPD have been reported. Among them, CT showed mild AP (e.g., parenchymal enlargement, expanded attenuation of the surrounding fat, fluid collection) in seven cases (24.1%) ([@B2], [@B4], [@B6], [@B8], [@B9], [@B11]), and CP (e.g., parenchymal atrophy, pancreatic stone) in 11 cases (36.7%) ([@B1], [@B3], [@B5], [@B7], [@B11]). The serum amylase level, which was documented in 26 cases, was reported to be almost normal or only slightly elevated ([@B2], [@B4], [@B8], [@B9], [@B11]). The main focus of the inflammation was thought to be the MPD rather than the pancreatic parenchyma, unlike in AP. The serum C-reactive protein (CRP) level was markedly high (＞10 mg/dL) in 12 (50.0%) of 24 cases in which it was documented ([@B2], [@B4], [@B6], [@B8], [@B10], [@B11]). This may reflect inflammation of the MPD in AOSPD. AOSPD should be considered when CT findings of MPD obstruction along with a dilated MPD and signs of mild pancreatitis limited to the distal pancreas are observed along with the characteristic laboratory data (a markedly elevated serum CRP level, and a roughly normal to slightly elevated serum pancreatic amylase level).

The hypothesized pathogenesis of AOSPD is as follows. MPD obstruction causes pancreatic juice stasis, but it does not usually cause suppurative ductitis, similar to the cause of acute obstructive suppurative cholangitis. Normally, pancreatic juice has a significant degree of antibacterial activity ([@B12]). In addition to MPD obstruction, the following features are considered to be risk factors for AOSPD: alcohol consumption, smoking, diabetes mellitus, immune dysfunction, a history of CP, or a prior ampullary procedure ([@B11]). Almost all previous cases of AOSPD had either a history of CP or an ampullary procedure. Thus, these two factors are considered to be essential for its development. CP is thought to contribute to the development of ASOPD because the pancreatic juice from patients with CP has impaired antibacterial activity ([@B12]). A prior ampullary procedure is thought to cause the reflux of bacteria from the gastrointestinal tract into the MPD though the injection of contrast material, guide wire insertion, or dysfunction of the papilla of Vater after EST. The characteristics of the previous cases of AOSPD in patients who had no history of a previous ampullary procedure are shown in [Table](#t001){ref-type="table"}. With the exception of one case ([@B10]), all of the AOSPD patients without a history of a previous ampullary procedure had a history of CP. The one exception showed a different pathogenesis from the other cases, in that intraductal papillary mucinous carcinoma caused the formation of a pancreatobiliary fistula, resulting in the development of a hepatic abscess and AOSPD ([@B10]).

The combination of pancreatic juice stasis with the reflux of bacteria into the MPD, an ampullary procedure or impaired antibacterial activity of the pancreatic juice, and CP is expected to cause uncontrolled bacterial proliferation.

###### 

Prior AOSPD Cases without Previous Ampullary Procedure (Endoscopic Sphincterectomy or Endoscopic Retrograde Pancreatography).

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Reference      Age/\      Relevant comorbid conditions   Alcohol   Smoking   DM    BT (°C)           WBC (/μL)         CRP (mg/dL)       Serum amylase (U/L)     CT scan findings
                 Gender                                                                                                                                            
  -------------- ---------- ------------------------------ --------- --------- ----- ----------------- ----------------- ----------------- ----------------------- ------------------------------------------------------------------
  6\)            53/male    CP, leukemia                   ND        ND        No    High fever (ND)   3,190             12.1              Normal level (ND)       pancreatic stones, parenchymal enlargement, fluid collection

  8\)            50/male    CP                             Yes       Yes       No    38.5              5,700             11.2              1,382                   parenchymal enlargement

  9\)            70/male    CP, IPMN                       ND        ND        ND    High fever (ND)   High level (ND)   High level (ND)   Slight elevation (ND)   parenchymal enlargement, pancreatic stone

  10\)           60s/male   IPMC                           Yes       Yes       Yes   38.0              12,300            16.2              31                      parenchymal atrophy

  11\)                                                                                                                                                             

  4 cases        62/male    CP                             Yes       Yes       No    38.5              17,200            26.0              33                      pancreatic stones

                 52/male    CP                             Yes       Yes       No    38                12,500            10.6              256                     pancreatic stones

                 41/male    CP                             Yes       Yes       No    37.1              12,100            3.1               133                     parenchymal atrophy

                 50/male    CP, DM                         Yes       Yes       No    37.6              13,000            14                213                     parenchymal atrophy

  Present case   62/male    DM                             No        Yes       Yes   38.1              11,300            14.5              350                     parenchymal enlargement, expanded attenuation of surrounding fat
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Among the 29 previously reported cases of AOSPD, most MPD obstruction was caused by CP and pancreatic stones ([@B1], [@B3], [@B5]-[@B9], [@B11]). Only four cases of AOSPD were associated with MPD obstruction caused by pancreatic carcinoma ([@B2], [@B4], [@B11]). In addition, all four of those cases had previously undergone EST or ERP. Our present case was unique in that it involved spontaneous AOSPD associated with MPD obstruction caused by pancreatic carcinoma, without a history of CP or a prior ampullary procedure.

In our case, the risk factors for AOSPD included smoking and diabetes mellitus. The exact pathogenesis of our case of AOSPD was unclear. However, diabetes mellitus might have contributed because it predisposes the patient to infection, and causes exocrine cell exhaustion, which may lead to the impairment antibacterial activity of pancreatic juice, as occurs in CP.

In conclusion, we herein reported a case of AOSPD associated with pancreatic carcinoma without a history of CP or an ampullary endoscopic procedure. To the best of our knowledge, there have been no previous reports of AOSPD with a similar pathogenesis. Further similar case reports should be collected to provide more information about the pathogenesis of this rare clinical entity.
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